Results

Total Results: over 10,000 records

Showing results for "diabetes treatment".
Users also searched for: diabetes guidelines

  1. www.ahrq.gov/sites/default/files/wysiwyg/professionals/prevention-chronic-care/decision/mcc/shah_grant.pdf
    September 01, 2013 - Optimizing the Treatment of Diabetes Patients Optimizing Prevention and Healthcare Management … for the Complex Patient – Pioneer R21 Grants Optimizing the Treatment of Diabetes Patients Principal … Therefore, it is important to identify optimal treatments for these highly complex patients so that … Increase clinical health research Optimizing the Treatment of Diabetes Patients (Continued) … Optimizing the start time of statin therapy for patients with diabetes.
  2. effectivehealthcare.ahrq.gov/products/diabetes-treatment
    January 24, 2012 - Treatment Intensification in Type 2 Diabetes Mellitus Timeline January 24, 2012 Topic … Initiated January 24, 2012 Abstract Archived Treatment Intensification … in Type 2 Diabetes Mellitus
  3. effectivehealthcare-admin.ahrq.gov/products/diabetes-treatment/abstract
    December 01, 2019 - : Treatment Intensification in Type 2 Diabetes Mellitus … Patients often have their DM therapies intensified to reach the recommended hemoglobin A1C (HbA1C) target … Three exposures will be examined: therapy intensified with an additional oral agent therapy intensified … Disease Project Timeline Treatment Intensification in Type 2 Diabetes Mellitus … https://effectivehealthcare.ahrq.gov/products/diabetes-treatment/abstract  
  4. effectivehealthcare.ahrq.gov/products/diabetes-treatment/abstract
    January 24, 2012 - Treatment Intensification in Type 2 Diabetes Mellitus Abstract Archived January 24, 2012 … Topic Abstract Background: Many patients with type 2 diabetes mellitus (DM) may have other major … Patients often have their DM therapies intensified to reach the recommended hemoglobin A1C (HbA1C) target … ; and, 2) therapy intensified during the first year with insulin. … Three exposures will be examined: therapy intensified with an additional oral agent therapy intensified
  5. Diabetes Mellitus (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/diabetes_hi_impact.pdf
    March 01, 2012 - Many patients with T2DM fail to meet treatment goals and require additional therapy with one of two … New treatments in development for all types of diabetes focus on several aspects of prevention to delay … treatment compliance Experts agreed that while any new therapy for the treatment of diabetes would … of T2DM Intervention SGLT2 inhibitors for treatment of T2DM While many current treatments help … A paradigm shift in diabetes therapy-- dapagliflozin and other SGLT2 inhibitors.
  6. Diabetes Mellitus (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/diabetes_hi_impact.pdf
    March 01, 2012 - Many patients with T2DM fail to meet treatment goals and require additional therapy with one of two … New treatments in development for all types of diabetes focus on several aspects of prevention to delay … treatment compliance Experts agreed that while any new therapy for the treatment of diabetes would … of T2DM Intervention SGLT2 inhibitors for treatment of T2DM While many current treatments help … A paradigm shift in diabetes therapy-- dapagliflozin and other SGLT2 inhibitors.
  7. Diabetes Mellitus (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/diabetes_hi_impact.pdf
    March 01, 2012 - Many patients with T2DM fail to meet treatment goals and require additional therapy with one of two … New treatments in development for all types of diabetes focus on several aspects of prevention to delay … treatment compliance Experts agreed that while any new therapy for the treatment of diabetes would … of T2DM Intervention SGLT2 inhibitors for treatment of T2DM While many current treatments help … A paradigm shift in diabetes therapy-- dapagliflozin and other SGLT2 inhibitors.
  8. Diabetes Mellitus (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/07_diabetes_potential_high_impact_june_2012.pdf
    January 01, 2012 - Many patients with T2DM do not meet treatment goals and require additional therapy with one of two … New treatments in development for all types of diabetes focus on delaying onset of the disease in at-risk … One expert with a clinical perspective also noted that initiation of treatment with this therapy might … Both treatments were generally well tolerated. … Treatment Adherence Diabetes Mellitus Interventions Artificial Pancreas for Treatment of Diabetes
  9. Diabetes Mellitus (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/07_diabetes_potential_high_impact_june_2012.pdf
    January 01, 2012 - Many patients with T2DM do not meet treatment goals and require additional therapy with one of two … New treatments in development for all types of diabetes focus on delaying onset of the disease in at-risk … One expert with a clinical perspective also noted that initiation of treatment with this therapy might … Both treatments were generally well tolerated. … Treatment Adherence Diabetes Mellitus Interventions Artificial Pancreas for Treatment of Diabetes
  10. Diabetes Mellitus (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/07_diabetes_potential_high_impact_2012-12-10.pdf
    January 01, 2012 - ) Therapy for Type 1 Diabetes Mellitus and Type 2 Diabetes Mellitus Requiring Insulin 5 Fluocinolone … New treatments in development for all types of diabetes focus on delaying disease onset in at- risk … of Type 2 Diabetes Mellitus  Key Facts: Two therapies for treating T2DM, one in development and … of Type 2 Diabetes Mellitus Two therapies for treating T2DM, one in development and one recently approved … of Diabetes Buccal Insulin (Oral-Lyn) Therapy for Type 1 Diabetes Mellitus and Type 2 Diabetes Mellitus
  11. Diabetes Mellitus (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/07_diabetes_potential_high_impact_2012-12-10.pdf
    January 01, 2012 - ) Therapy for Type 1 Diabetes Mellitus and Type 2 Diabetes Mellitus Requiring Insulin 5 Fluocinolone … New treatments in development for all types of diabetes focus on delaying disease onset in at- risk … of Type 2 Diabetes Mellitus  Key Facts: Two therapies for treating T2DM, one in development and … of Type 2 Diabetes Mellitus Two therapies for treating T2DM, one in development and one recently approved … of Diabetes Buccal Insulin (Oral-Lyn) Therapy for Type 1 Diabetes Mellitus and Type 2 Diabetes Mellitus
  12. Diabetes Mellitus (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/07_diabetes_potential_high_impact_2012-12-10.pdf
    January 01, 2012 - ) Therapy for Type 1 Diabetes Mellitus and Type 2 Diabetes Mellitus Requiring Insulin 5 Fluocinolone … New treatments in development for all types of diabetes focus on delaying disease onset in at- risk … of Type 2 Diabetes Mellitus  Key Facts: Two therapies for treating T2DM, one in development and … of Type 2 Diabetes Mellitus Two therapies for treating T2DM, one in development and one recently approved … of Diabetes Buccal Insulin (Oral-Lyn) Therapy for Type 1 Diabetes Mellitus and Type 2 Diabetes Mellitus
  13. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/treatment-outcomes-diabetes-rapid-research.pdf
    July 19, 2024 - mellitus, and to collect evidence on dental treatments influencing diabetes outcomes. … 46% • Differences in criteria adopted for the definition of periodontitis • Differences across therapeutic … Effect of Periodontal Therapy on Glycaemic Control in Type 2 Diabetes. … review Corbella 2023 36849595 Laser treatments as an adjunct to non-surgical periodontal therapy … Lucena 2017 Clinical and Metabolic Effects of two Periodontal Therapeutic Modalities in Diabetic
  14. Diabetes Mellitus (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1306.pdf
    January 01, 2016 - New treatments in development for diabetes focus on delaying disease onset in at-risk patients and … of Type 2 Diabetes Mellitus  Key Facts: Two therapies for treating T2DM, one in development and … therapies. … Other treatment options, such as anti-VEGF therapies are available for treating DME, and according … Intarcia Therapeutics. A study to evaluate ITCA 650 for the treatment of type 2 diabetes.
  15. Diabetes Mellitus (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1306.pdf
    January 01, 2016 - New treatments in development for diabetes focus on delaying disease onset in at-risk patients and … of Type 2 Diabetes Mellitus  Key Facts: Two therapies for treating T2DM, one in development and … therapies. … Other treatment options, such as anti-VEGF therapies are available for treating DME, and according … Intarcia Therapeutics. A study to evaluate ITCA 650 for the treatment of type 2 diabetes.
  16. Diabetes Mellitus (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1312.pdf
    January 01, 2016 - New treatments in development for diabetes focus on delaying disease onset in at-risk patients and … of Type 2 Diabetes Mellitus  Key Facts: Two therapies for treating T2DM, one in development and one … These studies evaluated the safety and efficacy of EQW compared with other diabetes therapies. … ., anti-VEGF therapies). … Intarcia Therapeutics. A study to evaluate ITCA 650 for the treatment of type 2 diabetes.
  17. Diabetes Mellitus (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1312.pdf
    January 01, 2016 - New treatments in development for diabetes focus on delaying disease onset in at-risk patients and … of Type 2 Diabetes Mellitus  Key Facts: Two therapies for treating T2DM, one in development and one … These studies evaluated the safety and efficacy of EQW compared with other diabetes therapies. … ., anti-VEGF therapies). … Intarcia Therapeutics. A study to evaluate ITCA 650 for the treatment of type 2 diabetes.
  18. Diabetes Mellitus (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1412.pdf
    January 01, 2015 - therapeutic effects and better glycemic control. … The mode of delivery, an implanted pump, is an established therapy for other drugs or other treatments … Unlike other treatments for T2DM, management of therapy with the ITCA 650 is controlled by the device … , corticosteroids, or anti-VEGF therapies, making this new intervention just another treatment option … Investigational therapeutic options in the management of DME: investigational pharmacologic treatments
  19. Diabetes Mellitus (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1412.pdf
    January 01, 2015 - therapeutic effects and better glycemic control. … The mode of delivery, an implanted pump, is an established therapy for other drugs or other treatments … Unlike other treatments for T2DM, management of therapy with the ITCA 650 is controlled by the device … , corticosteroids, or anti-VEGF therapies, making this new intervention just another treatment option … Investigational therapeutic options in the management of DME: investigational pharmacologic treatments
  20. Diabetes Mellitus (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1512.pdf
    December 01, 2015 - In a May 2015 review published in Diabetes Technology & Therapeutics of almost 21,000 patients who … 2 diabetes mellitus (T2DM) do not meet treatment goals and require additional therapy with one of … medications, behavioral and lifestyle therapies, glucose monitors, insulin pumps, and treatment protocols … medications, behavioral and lifestyle therapies, glucose monitors, insulin pumps, and treatment protocols … Investigational therapeutic options in the management of DME: investigational pharmacologic treatments